These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17320314)

  • 21. Irish injecting drug users and hepatitis C: the importance of the social context of injecting.
    Smyth BP; Barry J; Keenan E
    Int J Epidemiol; 2005 Feb; 34(1):166-72. PubMed ID: 15513970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Injecting practices in sexual partnerships: hepatitis C transmission potentials in a 'risk equivalence' framework.
    Harris M; Rhodes T
    Drug Alcohol Depend; 2013 Oct; 132(3):617-23. PubMed ID: 23664125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent trends in pharmaceutical drug use among frequent injecting drug users, frequent methamphetamine users and frequent ecstasy users in New Zealand, 2006-2009.
    Wilkins C; Sweetsur P; Griffiths R
    Drug Alcohol Rev; 2011 May; 30(3):255-63. PubMed ID: 21545555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "I inject less as I have easier access to pipes": injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed.
    Leonard L; DeRubeis E; Pelude L; Medd E; Birkett N; Seto J
    Int J Drug Policy; 2008 Jun; 19(3):255-64. PubMed ID: 18502378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users.
    Tucker T; Fry CL; Lintzeris N; Baldwin S; Ritter A; Donath S; Whelan G
    Addiction; 2004 Sep; 99(9):1157-66. PubMed ID: 15317636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand.
    Verachai V; Phutiprawan T; Theamboonlers A; Chinchai T; Tanprasert S; Haagmans BL; Osterhaus AD; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):849-51. PubMed ID: 12757237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.
    Maher L; Li J; Jalaludin B; Wand H; Jayasuriya R; Dixon D; Kaldor JM
    Drug Alcohol Depend; 2007 Jul; 89(2-3):244-50. PubMed ID: 17289299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of alcohol use among methadone maintenance patients by direct ethanol metabolites and self-reports.
    Wurst FM; Dürsteler-MacFarland KM; Auwaerter V; Ergovic S; Thon N; Yegles M; Halter C; Weinmann W; Wiesbeck GA
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1552-7. PubMed ID: 18616663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C vaccine clinical trials among people who use drugs: potential for participation and involvement in recruitment.
    Young AM; Stephens DB; Khaleel HA; Havens JR
    Contemp Clin Trials; 2015 Mar; 41():9-16. PubMed ID: 25553715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Motivations, substance use and other correlates amongst property and violent offenders who regularly inject drugs.
    Sutherland R; Sindicich N; Barrett E; Whittaker E; Peacock A; Hickey S; Burns L
    Addict Behav; 2015 Jun; 45():207-13. PubMed ID: 25705014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of injection and non-injection methamphetamine-using HIV positive men who have sex with men.
    Semple SJ; Patterson TL; Grant I
    Drug Alcohol Depend; 2004 Nov; 76(2):203-12. PubMed ID: 15488344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection.
    Batki SL; Canfield KM; Smyth E; Ploutz-Snyder R
    Drug Alcohol Depend; 2009 May; 101(3):176-82. PubMed ID: 19233573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-risk drug-use practices among a large sample of Australian prisoners.
    Kinner SA; Jenkinson R; Gouillou M; Milloy MJ
    Drug Alcohol Depend; 2012 Nov; 126(1-2):156-60. PubMed ID: 22658284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
    White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
    Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is hepatitis C infection associated with increased risk of depression in persons with methamphetamine dependence?
    Vigil O; Woods SP; Moran LM; Letendre SL; Young-Casey C; Grant I; Atkinson JH
    Am J Addict; 2007; 16(5):418-23. PubMed ID: 17882614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences in HIV risk behaviours among intravenous drug users in Catalonia, Spain.
    Folch C; Casabona J; Espelt A; Majó X; Meroño M; Gonzalez V; Brugal MT;
    Gac Sanit; 2013; 27(4):338-43. PubMed ID: 23578527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users.
    Grebely J; Genoway KA; Raffa JD; Dhadwal G; Rajan T; Showler G; Kalousek K; Duncan F; Tyndall MW; Fraser C; Conway B; Fischer B
    Drug Alcohol Depend; 2008 Jan; 93(1-2):141-7. PubMed ID: 17997050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.